Citigroup Inc Cogent Biosciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 68,416 shares of COGT stock, worth $554,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,416

Previous 39,330 73.95%

Holding current value

$554,853

Previous $331,000 122.96%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.24 - $11.48 $239,668 - $333,907	29,086 Added 73.95%	68,416 $738,000
Q2 2024 Aug 12, 2024	SELL	$6.01 - $9.04 $3.37 Million - $5.07 Million	-560,659 Reduced 93.44%	39,330 $331,000
Q1 2024 May 10, 2024	BUY	$4.38 - $9.02 $2.09 Million - $4.31 Million	478,138 Added 392.4%	599,989 $4.03 Million
Q4 2023 Feb 09, 2024	BUY	$4.06 - $10.08 $160,816 - $399,268	39,610 Added 48.16%	121,851 $716,000
Q3 2023 Nov 09, 2023	BUY	$9.69 - $13.34 $24,438 - $33,643	2,522 Added 3.16%	82,241 $801,000
Q2 2023 Aug 10, 2023	SELL	$9.85 - $13.24 $1.13 Million - $1.52 Million	-114,871 Reduced 59.03%	79,719 $943,000
Q1 2023 May 11, 2023	BUY	$10.04 - $15.5 $508,074 - $784,377	50,605 Added 35.15%	194,590 $2.1 Million
Q4 2022 Feb 09, 2023	SELL	$10.65 - $14.84 $514,256 - $716,579	-48,287 Reduced 25.11%	143,985 $1.66 Million
Q3 2022 Nov 10, 2022	BUY	$9.39 - $16.99 $537,746 - $972,983	57,268 Added 42.42%	192,272 $2.87 Million
Q2 2022 Aug 10, 2022	BUY	$3.92 - $9.73 $4,841 - $12,016	1,235 Added 0.92%	135,004 $1.22 Million
Q1 2022 May 12, 2022	SELL	$5.31 - $8.7 $43,695 - $71,592	-8,229 Reduced 5.8%	133,769 $1 Million
Q4 2021 Feb 10, 2022	SELL	$7.51 - $10.81 $846,234 - $1.22 Million	-112,681 Reduced 44.24%	141,998 $1.22 Million
Q3 2021 Nov 10, 2021	BUY	$5.99 - $9.14 $1.53 Million - $2.33 Million	254,679 New	254,679 $2.14 Million

Others Institutions Holding COGT

# of Institutions

172

Shares Held

113M

Call Options Held

56.7K

Put Options Held

40.4K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $533M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account